BRPI0419125A - composição farmacêutica e processo para a preparação de uma composição farmacêutica - Google Patents

composição farmacêutica e processo para a preparação de uma composição farmacêutica

Info

Publication number
BRPI0419125A
BRPI0419125A BRPI0419125-0A BRPI0419125A BRPI0419125A BR PI0419125 A BRPI0419125 A BR PI0419125A BR PI0419125 A BRPI0419125 A BR PI0419125A BR PI0419125 A BRPI0419125 A BR PI0419125A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
polymer
compositions
lipid
bitter
Prior art date
Application number
BRPI0419125-0A
Other languages
English (en)
Inventor
Anupa Ramesh Menjoge
Mohan Gopalkrishna Kulkarni
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BRPI0419125A publication Critical patent/BRPI0419125A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIçãO FARMACêUTICA E PROCESSO PARA A PREPARAçãO DE UMA COMPOSIçãO FARMACéUTICA A presente invenção revela composições compreendendo uma matriz de lipídio - polímero para mascarar o sabor amargo ou desagradável de um medicamento. O lipídio ou uma mescla de lipídios é usado em combinação com um polímero dependente de pH onde o referido polímero é solúvel ou inflável em ácido. O processo para a preparação das composições farmacêuticas que mascaram o sabor amargo de drogas compreendendo as referidas composições de lipídio - polímero é aqui revelado. O uso concomitante de um polímero solúvel em ácido, o qual permanece em colapso no pH da saliva, inibe a liberação da droga naquele pH e dai portanto o mesmo ajuda na inibição do sabor amargo. As referidas composições liberam imediatamente uma quantidade substancial da droga amarga no pH gástrico com uma palatização aperfeiçoada.
BRPI0419125-0A 2004-12-10 2004-12-10 composição farmacêutica e processo para a preparação de uma composição farmacêutica BRPI0419125A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2004/000379 WO2006061846A1 (en) 2004-12-10 2004-12-10 Pharmaceutical composition for improving palatability of drugs and process for preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0419125A true BRPI0419125A (pt) 2007-12-11

Family

ID=35094449

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0419125-0A BRPI0419125A (pt) 2004-12-10 2004-12-10 composição farmacêutica e processo para a preparação de uma composição farmacêutica

Country Status (6)

Country Link
EP (1) EP1845937A1 (pt)
JP (1) JP4629730B2 (pt)
CN (1) CN100548270C (pt)
AU (1) AU2004325469B2 (pt)
BR (1) BRPI0419125A (pt)
WO (1) WO2006061846A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101084881B (zh) * 2007-06-23 2012-08-29 淮北辉克药业有限公司 靶向速释泡腾制剂及其制备方法
JP5563841B2 (ja) * 2010-02-05 2014-07-30 沢井製薬株式会社 薬物の不快な味をマスキングした経口医薬組成物
BR112015005876A2 (pt) * 2012-09-18 2017-07-04 Mcneil Ppc Inc partículas derivadas de ácido propiônico com baixo ponto de fusão para uso em formas de dosagem oral
WO2015130760A1 (en) * 2014-02-25 2015-09-03 Orbis Biosciences, Inc. Taste masking drug formulations
US11896037B2 (en) * 2016-08-03 2024-02-13 Temple University-Of The Commonwealth System Of Higher Education Microencapsulation of active agents
CN106727337A (zh) * 2016-12-13 2017-05-31 河南后羿实业集团有限公司 一种恩诺沙星可溶性粉及其制备方法
JP2023500472A (ja) * 2019-10-28 2023-01-06 ブリリアン・ファーマ・インコーポレイテッド 経口乾燥溶液及び懸濁物のための医薬品単位用量システム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT943160B (it) * 1971-02-19 1973-04-02 Rohm & Haas Foglio adesivo sensibile alla pres sione privo di soppurto e di spes sore sostanziale particolarmente per il fissaggio di oggetti rigidi su superfici di maggiore ampiezza
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US5149775A (en) * 1991-01-25 1992-09-22 Eastman Kodak Company Method for purifying high molecular weight vinylpyridine/styrene polymers from solution
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
DE19918435A1 (de) * 1998-07-23 2000-01-27 Roehm Gmbh Überzugs- und Bindemittel für orale oder dermale Arzneiformen
US6039979A (en) * 1999-01-13 2000-03-21 Laboratoires Prographarm Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation

Also Published As

Publication number Publication date
JP4629730B2 (ja) 2011-02-09
WO2006061846A1 (en) 2006-06-15
EP1845937A1 (en) 2007-10-24
AU2004325469B2 (en) 2009-02-05
AU2004325469A1 (en) 2006-06-15
JP2008506770A (ja) 2008-03-06
CN1953734A (zh) 2007-04-25
CN100548270C (zh) 2009-10-14

Similar Documents

Publication Publication Date Title
BR0307540A (pt) Preparação farmacêutica em forma de filme ou em forma de lâmina para administrar substâncias ativas, uso da preparação farmacêutica e processo para a administração oral de substância(s) farmaceuticamente ativa(s) dotadas de sabor amargo
CA2705733C (en) Reduced dose intravenous acetaminophen
BRPI0513300A (pt) forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
BRPI0508540A8 (pt) Composto, composição farmacêutica, e, uso de um composto
ES2906803T3 (es) Composiciones útiles para la prevención y/o el tratamiento de los trastornos de la cavidad oral, las vías respiratorias superiores y el esófago
BRPI0707235B8 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
BR0111916A (pt) Métodos e composição para vacinação oral
EP3969054A1 (en) Oil-soluble drug containing compositions and methods of use thereof
BRPI0608877B8 (pt) composição imunogênica de rotavírus líquida, uso de um antígeno de rotavírus, um açúcar e um carboxilato, e, método para a preparação de uma composição de rotavírus líquida
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
AR076153A1 (es) Forma de dosificacion intra-oral de multiples porciones con propiedades organolepticas. formulaciones
BRPI0517891A (pt) composições compreendendo azelastina e métodos de uso das mesmas
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
CY1114442T1 (el) Διασφαλισμενη εναντια σε καταχρηση, στοματικη μορφη χορηγησης που περιεχει (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολη
BRPI0706992C8 (pt) composto de fórmula (i) e formulação farmacêutica
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
ES2948788T3 (es) Composiciones y métodos para mejorar la biodisponibilidad del 5-hidroxitriptófano
BRPI0413112A (pt) compostos de indol-6 sulfonamida, processos de obtenção de seus derivados, seus medicamentos e usos como moduladores de 5-ht-6
BRPI0519280A2 (pt) composto, composiÇço farmacÊutica e uso de um composto
BRPI0515070A2 (pt) sistema de entrega de medicamento auto-emulsificante de butilftalida, sua preparação e método de aplicação
BRPI0419125A (pt) composição farmacêutica e processo para a preparação de uma composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE(S)

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B11T Dismissal of application maintained [chapter 11.20 patent gazette]